A Pilot Study of Pazopanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase 0
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 26 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Mar 2015 Planned initiation date changed from 1 Nov 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.